Free Trial
OTCMKTS:EVTCY

Evotec (EVTCY) Stock Price, News & Analysis

Evotec logo
$3.88 -0.12 (-3.00%)
As of 10/17/2025

About Evotec Stock (OTCMKTS:EVTCY)

Advanced

Key Stats

Today's Range
$3.85
$3.92
50-Day Range
$3.37
$4.01
52-Week Range
$14.22
$26.57
Volume
34,772 shs
Average Volume
2,407 shs
Market Capitalization
$1.28 billion
P/E Ratio
9.46
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVTCY Stock News Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

EVTCY Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at $4.16 on January 1st, 2025. Since then, EVTCY stock has decreased by 6.7% and is now trading at $3.88.

Evotec's stock split on the morning of Wednesday, October 20th 2021.The 3-1 split was announced on Wednesday, October 20th 2021. The newly issued shares were issued to shareholders after the market closes on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

The following companies are subsidiaries of Evotec: Central Glass Germany. GmbH, Central Glass Germany, Rigenerand Srl, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, Aptuit, Cyprotex, and more.

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EVTCY
CIK
1412558
Employees
4,200
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
$0.41
Trailing P/E Ratio
9.46
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.14 million
Net Margins
20.85%
Pretax Margin
23.90%
Return on Equity
16.02%
Return on Assets
7.81%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.57
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$572.16 million
Price / Sales
2.24
Cash Flow
$0.04 per share
Price / Cash Flow
105.53
Book Value
$2.52 per share
Price / Book
1.54

Miscellaneous

Outstanding Shares
330,221,000
Free Float
N/A
Market Cap
$1.28 billion
Optionable
Not Optionable
Beta
0.98

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:EVTCY) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners